Your browser doesn't support javascript.
loading
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis.
Baumdick, Martin E; Niehrs, Annika; Degenhardt, Frauke; Schwerk, Maria; Hinrichs, Ole; Jordan-Paiz, Ana; Padoan, Benedetta; Wegner, Lucy H M; Schloer, Sebastian; Zecher, Britta F; Malsy, Jakob; Joshi, Vinita R; Illig, Christin; Schröder-Schwarz, Jennifer; Möller, Kimberly J; Martin, Maureen P; Yuki, Yuko; Ozawa, Mikki; Sauter, Jürgen; Schmidt, Alexander H; Perez, Daniel; Giannou, Anastasios D; Carrington, Mary; Davis, Randall S; Schumacher, Udo; Sauter, Guido; Huber, Samuel; Puelles, Victor G; Melling, Nathaniel; Franke, Andre; Altfeld, Marcus; Bunders, Madeleine J.
Afiliação
  • Baumdick ME; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Niehrs A; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Degenhardt F; Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany.
  • Schwerk M; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hinrichs O; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Jordan-Paiz A; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Padoan B; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Wegner LHM; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Schloer S; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany; Research Group Regulatory Mechanisms of Inflammation, Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, and Cells in Motion Interfaculty Center, University of Münster, Münster, Germany.
  • Zecher BF; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Malsy J; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems, Germany.
  • Joshi VR; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Illig C; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Schröder-Schwarz J; Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Möller KJ; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Martin MP; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Yuki Y; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Ozawa M; One Lambda, Inc, Canoga Park, California.
  • Sauter J; DKMS, Tübingen, Germany.
  • Schmidt AH; DKMS, Tübingen, Germany; DKMS Life Science Laboratory, Dresden, Germany.
  • Perez D; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Giannou AD; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Translational Immuno
  • Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massa
  • Davis RS; Departments of Medicine, Microbiology, and Biochemistry and Molecular Genetics, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.
  • Schumacher U; Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Huber S; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Translational Immunology, University Medical Ce
  • Puelles VG; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Pathology, Aarhus University
  • Melling N; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany.
  • Altfeld M; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
  • Bunders MJ; Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Section of Regenera
Gastroenterology ; 165(4): 946-962.e13, 2023 10.
Article em En | MEDLINE | ID: mdl-37454979
ABSTRACT
BACKGROUND &

AIMS:

Ulcerative colitis (UC) is characterized by severe inflammation and destruction of the intestinal epithelium, and is associated with specific risk single nucleotide polymorphisms in HLA class II. Given the recently discovered interactions between subsets of HLA-DP molecules and the activating natural killer (NK) cell receptor NKp44, genetic associations of UC and HLA-DP haplotypes and their functional implications were investigated.

METHODS:

HLA-DP haplotype and UC risk association analyses were performed (UC n = 13,927; control n = 26,764). Expression levels of HLA-DP on intestinal epithelial cells (IECs) in individuals with and without UC were quantified. Human intestinal 3-dimensional (3D) organoid cocultures with human NK cells were used to determine functional consequences of interactions between HLA-DP and NKp44.

RESULTS:

These studies identified HLA-DPA1∗0103-DPB1∗0401 (HLA-DP401) as a risk haplotype and HLA-DPA1∗0103-DPB1∗0301 (HLA-DP301) as a protective haplotype for UC in European populations. HLA-DP expression was significantly higher on IECs of individuals with UC compared with controls. IECs in human intestinal 3D organoids derived from HLA-DP401pos individuals showed significantly stronger binding of NKp44 compared with HLA-DP301pos IECs. HLA-DP401pos IECs in organoids triggered increased degranulation and tumor necrosis factor production by NKp44+ NK cells in cocultures, resulting in enhanced epithelial cell death compared with HLA-DP301pos organoids. Blocking of HLA-DP401-NKp44 interactions (anti-NKp44) abrogated NK cell activity in cocultures.

CONCLUSIONS:

We identified an UC risk HLA-DP haplotype that engages NKp44 and activates NKp44+ NK cells, mediating damage to intestinal epithelial cells in an HLA-DP haplotype-dependent manner. The molecular interaction between NKp44 and HLA-DP401 in UC can be targeted by therapeutic interventions to reduce NKp44+ NK cell-mediated destruction of the intestinal epithelium in UC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Antígenos HLA-DP Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Antígenos HLA-DP Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article